Add to favorite
Subscribe to our Newsletters Subscribe to our Newsletters Get Daily Updates RSS

Clinical Trials of Insulin in Russia are Probably Fake
November 10, 2010 23:24

Former top manager of MannKind, an American biotechnological company, sues his employers for falsifying results of clinical trials of their anti-diabetes drug in Russia. Diabetes is a group of metabolic problems, due to which human body doesn't produce enough insulin to control blood sugar (Type I), or organism's cells do not adequately react to insulin produced (Type II).

Biotechnologists of MannKind company have been performing clinical trials of their new diabetes treatment in the Russian Federation and at the same time have negotiated with Moscow government about further cooperation. John Arditi, former senior director for regulatory affairs of MannKind company, accuses the company in misreporting results, obtained during testing the newest anti-diabetes treatment in our country.

Mr. Arditi's lawsuit is related to "Afrezza", insulin for inhalations. Insulin is a substance, which helps those, suffering from diabetes, control sugar content in their blood. "Afrezza"'s reported benefit is that patients with diabetes do not receive insulin with injections, but simply inhale it; insulin dissolves in patient's lungs and enters his blood stream. The inhaler is as small as palm of a hand. The drug, useful for patients with both types of diabetes is currently reviewed by FDA (Food and Drug Administration, USA).



Structure of insulin
The lawsuit, claiming clinical trials "scientifically negligent", is based upon several facts, one of which is same blood pressure in all Russian patients, who have participated in the trials, during several months of the trials. Mr. Arditi, who lost his job soon after he told FDA about suspicious trials, suggests the trials could have been based upon fictitious patients. However, MannKind biotechnological company denies everything and claims that independent experts didn't find anything wrong in the trial procedure and results.

Experts believe that John Arditi's lawsuit may be a serious problem for approval of insulin inhaler by FDA. The lawsuit has already caused a significant drop of MannKind’s shares. Former head of the Moscow government has met the head of MannKind's CEO Alfred Mann last year – the discussion between the two businessmen was dedicated to possible cooperation with the capital's health and biotechnological establishments in the field of treating diabetes, a serious and dangerous disease.

However, some experts think that insulin inhalations aren't a perfect solution for patients with diabetes. Delicate cells of alveolus aren't suitable for delivering insulin into blood stream, they say, because lungs were designed for dealing with gases. Insulin injections nowadays are almost painless, because insulin is injected with tiny and very sharp needles. Sometimes insulin is sold inside a syringe, which is very convenient, since you don't have to do anything with ampoules. Sometimes patients take insulin for tens of years, and consequences of a long-term inhaling of insulin are not studied enough, medical experts say.


Kizilova Anna

Tags: Russian scientists Russian science health Russian medicine  

Next Previous

You might also find interesting:

Health and Aducational Centre - Ebola - Opens in Moscw Russia and the World: Russian Peoples Point of View Oil Production: Temperance and Abstention 6th International Skolkovo Robotics Forum in Moscow Space Research Institute of RAS: There Was Possibly Life on Venus

Comment on our site

RSS   twitter      submit

National Dishes  Russian economy  Russian space exploration  Russian Railways  Hulk  Russian tourism  Vladimir Medinsky  Russian Cinema  Exhibitions in Moscow  Mindaugas Karbauskis  World War I  Mercedes-Benz Fashion Week Russia  Russian arms  alcohol in Russia   Pertsov's House  Central Bank  Battle for Sevastopol  Tragedy  Moscow  airport transfer in Russia  Aeroexpress  Big Four  space  St. Petersburg  Russian Orthodox Chruch  human rights  Suzdal  Sergey Filin  Martial Arts  Russian scientists  Flood in the Far East   Russian Avant-Garde  Alla Pugacheva  Russian science  Russian business  Exhibition of National Economy Achievements  Mikhail Prokhorov  Moscow Theatres  human rights activists  Russian events  Terek  Russian children  Ryazan  Winzavod  Crimea  the Kazan Kremlin  Russian natural reserves  Russian National Dance Show "Kostroma"  IT  Russian banks 

Travel Blogs
Top Traveling Sites